Patents by Inventor Chen-Kung Chou

Chen-Kung Chou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HURP gene as a molecular marker for bladder cancer
    Patent number: 7217515
    Abstract: Hepatoma up-regulated protein (HURP) gene serves as a useful molecular marker in the detection, preliminary screening and monitoring of bladder cancer in a human subject. A method for the detection of bladder cancer, in particular transitional cell carcinoma (TCC) of the bladder, in a human subject is disclosed, in which the detected expression of the human HURP gene in a sample taken from a subject suspected to have bladder cancer is indicative of the presence of the bladder cancer. The present invention further provides a non-invasive method for the detection, preliminary screening or monitoring of urinary TCC in a suspected subject, in which a urine sample taken from the subject is analyzed to determine an expression of the human HURP gene, the presence of which is indicative of the presence of urinary TCC.
    Type: Grant
    Filed: September 30, 2002
    Date of Patent: May 15, 2007
    Assignee: Chi Mei Foundation Medical Center
    Inventors: Allen W. Chiu, Yu-Lun Huang, Chen-Kung Chou
  • Fullerene pharmaceutical compositions for preventing or treating disorders
    Patent number: 6777445
    Abstract: The present invention relates to a method for treating a disease, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a fullerene. The diseases treated comprise bacterial and viral diseases such as those cause by Gram positive and Gram negative bacteria, Dengue 2 virus and viral encephalitis. The fullerene is administered in vivo in an amount of about 0.001 to about 100 mg/kg of body weight of the subject.
    Type: Grant
    Filed: October 17, 2001
    Date of Patent: August 17, 2004
    Assignee: National Health Research Institute
    Inventors: Huan-Yao Lei, Chen-Kung Chou, Tien-Yau Luh
  • HURP gene as a molecular marker for bladder cancer
    Publication number: 20040072166
    Abstract: Hepatoma up-regulated protein (HURP) gene serves as a useful molecular marker in the detection, preliminary screening and monitoring of bladder cancer in a human subject. A method for the detection of bladder cancer, in particular transitional cell carcinoma (TCC) of the bladder, in a human subject is disclosed, in which the detected expression of the human HURP gene in a sample taken from a subject suspected to have bladder cancer is indicative of the presence of the bladder cancer. The present invention further provides a non-invasive method for the detection, preliminary screening or monitoring of urinary TCC in a suspected subject, in which a urine sample taken from the subject is analyzed to determine an expression of the human HURP gene, the presence of which is indicative of the presence of urinary TCC.
    Type: Application
    Filed: September 30, 2002
    Publication date: April 15, 2004
    Applicant: CHI MEI FOUNDATION MEDICAL CENTER
    Inventors: Allen W. Chiu, Yu-Lun Huang, Chen-Kung Chou
  • Cell cycle regulator protein
    Publication number: 20030027171
    Abstract: This invention relates to new cell cycle regulatory proteins and nucleic acids encoding them.
    Type: Application
    Filed: January 18, 2002
    Publication date: February 6, 2003
    Inventors: Chu-Wen Yang, Ann-Ping Tsou, Chin-Wen Chi, Ming-Ji Fann, Chen-Kung Chou
  • Fullerene pharmaceutical compositions for preventing or treating disorders
    Publication number: 20020098180
    Abstract: The present invention relates to a method for treating a disease, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a fullerene. The diseases treated comprise bacterial and viral diseases such as those cause by Gram positive and Gram negative bacteria, Dengue 2 virus and viral encephalitis. The fullerene is administered in vivo in an amount of about 0.001 to about 100 mg/kg of body weight of the subject.
    Type: Application
    Filed: October 17, 2001
    Publication date: July 25, 2002
    Inventors: Huan-Yao Lei, Chen-Kung Chou, Tien-Yau Luh
  • Inhibition and treatment of Hepatitis B virus and Flavivirus by Helioxanthin and its analogs
    Patent number: 6306899
    Abstract: This invention relates to anti-viral drugs such as Helioxanthin and its analogs. The present compounds may be used alone or in combination with other drugs for the treatment of Hepatitis B virus (HBV), Hepatitis C virus (HCV), Yellow Fever, Dengue Virus, Japanese Encephalitis, West Nile virus and related flaviviruses. In addition, compounds according to the present invention can be used to prevent hepatoma secondary to virus infection as well as other infections or disease states which are secondary to the virus infection.
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: October 23, 2001
    Assignees: Yale University, N. Y. Mu, N.T.U., V.G.H
    Inventors: Yung-Chi Cheng, Chen-Kung Chou, Lei Fu, Yueh-Hsiung Kuo, Sheau-Farn Yeh, Juliang Zhu, Yonglian Zhu